Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - COMMON STOCK REPURCHASED
Common Stock Repurchased IBRX - ImmunityBio, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR